|Application ||WB, IH|
|Reactivity||Human, Mouse, Rat|
|Calculated MW||24678 Da|
|Positive Control||WB: HT29, RAW264.7, mouse spleen, rat spleen lysate; IHC: human liver cancer tissue, IF/IC: HT29 cells|
|Application & Usage||WB; 1:500 – 1:2000, IH; 1:100 – 1:200, IF/IC; 1:100 – 1:500|
|Other Names||Cell death activator CIDE-B; Cell death-inducing DFFA-like effector B|
|Handling||The antibody solution should be gently mixed before use|
|Reconstitution & Storage||-20°C|
|Precautions||Anti-CIDEB Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Highly expressed in liver and small intestine and, at lower levels, in colon, kidney and spleen|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.